A comprehensive view of hospital / clinical drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Innoviva's Xacduro gains FDA approval to treat hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus complex; WHO reports Acinetobacter is the highest-risk bacterial pathogen for human health
Published:
May 25, 2023
by MarketLine
|
Fresenius Kabi, a provider of injectable medications, launches Rocuronium Bromide Injection with advanced RFID-enabled labels, its first product compatible with Bluesight’s KitCheck System, a kit and tray solution for hospitals allowing use of RFID
Published:
May 24, 2023
by Kit Check Inc.
|
Pfizer warns Indian clinicians to stop using four antibiotics due to manufacturing issues at contract producer Astral Steritech; drugs include Magnex, Zosyn, Magnamycin and Magnex Forte
Published:
May 18, 2023
by FiercePharma
|
AstraZeneca refreshes Fasenra asthma drug marketing to offer consistent messaging to physicians and patients for the first time; 'Move Forward' campaign pairs consumer-focused message with materials aimed at doctors
Published:
May 17, 2023
by FiercePharma
|
Executive Perspective: Pfizer CEO calls US plan to negotiate Medicare drug prices 'negotiation with a gun to your head' and expects legal action from drug industry; US seeks to save US$25B by 2031 with drug pricing reform plan
Published:
May 12, 2023
by Zawya
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count